| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 11018486 | Journal of Microbiology, Immunology and Infection | 2018 | 8 Pages | 
Abstract
												When treating MAC diseases, species identification plays an important role in choosing treatment regimens. Combination of isepamicin and clofazimine may be a promising regimen in M. intracellulare-associated disease.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Chen-Cheng Huang, Ming-Feng Wu, Hui-Chen Chen, Wei-Chang Huang, 
											